Optinose’s XHANCE Added to Express Scripts’ National Formularies
YARDLEY, PA — Optinose (NASDAQ: OPTN) announced this week that its drug XHANCE® (fluticasone propionate) has been added to Express Scripts’ national formularies. These include the National Preferred, Flex, and …
Optinose’s XHANCE Added to Express Scripts’ National Formularies Read More